Role of gut barrier function in the pathogenesis of nonalcoholic fatty liver disease

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Dai, Xin ^a   Wang, Bangmao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

ENZYME ACTIVATION; GUT BARRIER FUNCTION; HUMAN; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE FUNCTION; LIVER; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PERMEABILITY; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

EID: 84928473624     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/287348     Document Type: Review

References (48)

1. P. Angulo, "Medical progress: nonalcoholic fatty liver disease, " The New England Journal of Medicine, vol. 346, no. 16, pp. 1221-1231, 2002.
2. D. G. Tiniakos, M. B. Vos, and E. M. Brunt, "Nonalcoholic fatty liver disease: pathology and pathogenesis, " Annual Review of Pathology: Mechanisms of Disease, vol. 5, pp. 145-171, 2010.
3. G. C. Farrell and C. Z. Larter, "Nonalcoholic fatty liver disease: from steatosis to cirrhosis, " Hepatology, vol. 43, no. 2, supplement 1, pp. S99-S112, 2006.
4. V. Racanelli and B. Rehermann, "The liver as an immunological organ, " Hepatology, vol. 43, no. 2, pp. S54-S62, 2006.
5. M. L. Balmer, E. Slack, A. de Gottardi et al., "The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota, " Science Translational Medicine, vol. 6, no. 237, Article ID237ra66, 2014.
6. J. M. Ridlon, D. J. Kang, P. B. Hylemon, and J. S. Bajaj, "Bile acids and the gut microbiome, " Current Opinion in Gastroenterology, vol. 30, no. 3, pp. 332-338, 2014.
7. Å. V. Keita and J. D. Sderholm, Barrier dysfunction and bacterial uptake in the follicle-associated epithelium of ileal Crohn's disease Annals of the New York Academy of Sciences, 1258, 1, 125-134, 2012.
8. F. Scaldaferri, M. Pizzoferrato, V. Gerardi, L. Lopetuso, and A. Gasbarrini, "The gut barrier: new acquisitions and therapeutic approaches, " Journal of Clinical Gastroenterology, vol. 46, supplement, pp. S12-S17, 2012.
9. L. Miele, V. Valenza, G. La Torre et al., "Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease, " Hepatology, vol. 49, no. 6, pp. 1877-1887, 2009.
10. A. Rahimi, N. E. Daryani, H. Ghofrani et al., "The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran, " Turkish Journal of Gastroenterology, vol. 22, no. 3, pp. 300-304, 2011.
11. U. Navaneethan, V. Jayanthi, and P. Mohan, "Pathogenesis of cholangitis in obstructive jaundice-revisited, " Minerva Gastroenterologica e Dietologica, vol. 57, no. 1, pp. 97-104, 2011.
12. G. Szabo, "Gut-liver axis in alcoholic liver disease, " Gastroenterology, vol. 148, no. 1, pp. 30-36, 2015.
13. B. Shao, M. Lu, S. C. Katz et al., "Ahost lipase detoxifies bacterial lipopolysaccharides in the liver and spleen, " The Journal of Biological Chemistry, vol. 282, no. 18, pp. 13726-13735, 2007.
14. E. Jirillo, D. Caccavo, T. Magrone et al., "The role of the liver in the response to LPS: experimental and clinical findings, " Journal of Endotoxin Research, vol. 8, no. 5, pp. 319-327, 2002.
15. A. F. Hofmann, "Bile acids: the good, the bad, and the ugly, " News in Physiological Sciences, vol. 14, no. 1, pp. 24-29, 1999.
16. M. Begley, C. G. M. Gahan, and C. Hill, "The interaction between bacteria and bile, " FEMSMicrobiology Reviews, vol. 29, no. 4, pp. 625-651, 2005.
17. V. Volynets, A. Spruss, G. Kanuri, S. Wagnerberger, S. C. Bischoff, and I. Bergheim, "Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice, " Journal of Lipid Research, vol. 51, no. 12, pp. 3414-3424, 2010.
18. T. Claudel, E. Sturm, H. Duez et al., "Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element, " The Journal of Clinical Investigation, vol. 109, no. 7, pp. 961-971, 2002.
19. N. L. Urizar, D. H. Dowhan, and D. D. Moore, "Thefarnesoid Xactivated receptormediates bile acid activation of phospholipid transfer protein gene expression, " The Journal of Biological Chemistry, vol. 275, no. 50, pp. 39313-39317, 2000.
20. I. V. Martin, J. Schmitt, A. Minkenberg et al., "Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice, " Biological Chemistry, vol. 391, no. 12, pp. 1441-1449, 2010.
21. L. Pumbwe, C. A. Skilbeck, V. Nakano, M. J. Avila-Campos, R. M. F. Piazza, and H. M. Wexler, "Bile salts enhance bacterial coaggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis, " Microbial Pathogenesis, vol. 43, no. 2, pp. 78-87, 2007.
22. K. Miura, E. Seki, H. Ohnishi, and D. A. Brenner, "Role of tolllike receptors and their downstream molecules in the development of nonalcoholic fatty liver disease, " Gastroenterology Research and Practice, vol. 2010, Article ID362847, 9 pages, 2010.
23. M.-F. Tsan and B. Gao, "Endogenous ligands of Toll-like receptors, " Journal of Leukocyte Biology, vol. 76, no. 3, pp. 514-519, 2004.
24. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, "TLR4 links innate immunity and fatty acid-induced insulin resistance, "The Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015-3025, 2006.
25. C. Erridge and N. J. Samani, "Saturated fatty acids do not directly stimulate toll-like receptor signaling, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 11, pp. 1944-1949, 2009.
26. T. Kawai and S. Akira, "The role of pattern-recognition receptors in innate immunity: update on toll-like receptors, " Nature Immunology, vol. 11, no. 5, pp. 373-384, 2010.
27. A. W. Ferrante Jr., "Obesity-induced inflammation: a metabolic dialogue in the language of inflammation, " Journal of Internal Medicine, vol. 262, no. 4, pp. 408-414, 2007.
28. C. Erridge, "Diet, commensals and the intestine as sources of pathogen-associatedmolecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease, " Atherosclerosis, vol. 216, no. 1, pp. 1-6, 2011.
29. J. C. Alverdy and E. Aoys, "The effect of dexamethasone and endotoxin administration on biliary IgA and bacterial adherence, " Journal of Surgical Research, vol. 53, no. 5, pp. 450-454, 1992.
30. O. Pabst, "Newconcepts in the generation and functions of IgA, " Nature Reviews Immunology, vol. 12, no. 12, pp. 821-832, 2012.
31. S. Li, W. Wu, C. He, Z. Han, and D. Jin, "The protective effect of glutamine on the intestinal mucosa barrier function in non-alcoholic steatohepatitis rats, " Chinese Journal of Clinical Gastroenterology, vol. 20, pp. 241-244, 2008.
32. S. J. Creely, P. G. McTernan, C. M. Kusminski et al., "Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 292, no. 3, pp. E740-E747, 2007.
33. P. D. Cani, J. Amar, M. A. Iglesias et al., "Metabolic endotoxemia initiates obesity and insulin resistance, " Diabetes, vol. 56, no. 7, pp. 1761-1772, 2007.
34. K. Cope, T. Risby, and A. M. Diehl, "Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis, " Gastroenterology, vol. 119, no. 5, pp. 1340-1347, 2000.
35. S. Nair, K. Cope, T. H. Risby, and A. M. Diehl, "Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis, " American Journal of Gastroenterology, vol. 96, no. 4, pp. 1200-1204, 2001.
36. M.-E. Dumas, R. H. Barton, A. Toye et al., "Metabolic profiling reveals a contribution of gutmicrobiota to fatty liver phenotype in insulin-resistant mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 33, pp. 12511-12516, 2006.
37. M. D. Spencer, T. J. Hamp, R. W. Reid, L. M. Fischer, S. H. Zeisel, and A. A. Fodor, "Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency, " Gastroenterology, vol. 140, no. 3, pp. 976-986, 2011.
38. T. H. Frazier, J. K. DiBaise, and C. J. McClain, "Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury, " Journal of Parenteral and EnteralNutrition, vol. 35, no. 5, pp. 14S-20S, 2011.
39. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, "An obesity-associated gut microbiomewith increased capacity for energy harvest, " Nature, vol. 444, no. 7122, pp. 1027-1031, 2006.
40. F. Bckhed, H. Ding, T. Wang et al., "The gut microbiota as an environmental factor that regulates fat storage, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 44, pp. 15718-15723, 2004.
41. N. M. Delzenne and P. D. Cani, "Gut microflora is a key player in host energy homeostasis, " Medecine Sciences, vol. 24, no. 5, pp. 505-510, 2008.
42. J. Y. Myeong, Y. L. Gha, J.-J. Chung, H. A. Young, H. H. Seung, and B. K. Jae, "Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMPactivated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor α, " Diabetes, vol. 55, no. 9, pp. 2562-2570, 2006.
43. D. F. Lappin, S. Sherrabeh, and C. Erridge, "Stimulants of tolllike receptors 2 and 4 are elevated in saliva of periodontitis patients compared with healthy subjects, " Journal of Clinical Periodontology, vol. 38, no. 4, pp. 318-325, 2011.
44. C. Erridge, "Accumulation of stimulants of Toll-like receptor (TLR)-2 and TLR4 in meat products stored at 5°C, " Journal of Food Science, vol. 76, no. 2, pp. H72-H79, 2011.
45. A. J. Wigg, I. C. Roberts-Thomson, R. B. Dymock, P. J. McCarthy, R. H. Grose, and A. G. Cummins, "The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis, " Gut, vol. 48, no. 2, pp. 206-211, 2001.
46. N. Kamada and G. Nñez, "Regulation of the immune system by the resident intestinal bacteria, " Gastroenterology, vol. 146, no. 6, pp. 1477-1488, 2014.
47. E. Gbele, K. Dostert, C. Hofmann et al., "DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimentalNASH, " Journal of Hepatology, vol. 55, no. 6, pp. 1391-1399, 2011.
48. G. Paolella, C. Mandato, L. Pierri, M. Poeta, M. Di Stasi, and P. Vajro, "Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease, " World Journal of Gastroenterology, vol. 20, no. 42, pp. 15518-15531, 2014.